Adjusted EBITDA times a multiple gives the enterprise value; the debt, the manufacturer's loan, fees and rollover decide what the owner actually receives.
An audiology practice is worth its adjusted EBITDA times a multiple, less the debt repaid at closing, with fees and any rollover taken from the equity. In the book's fictional case a manufacturer-affiliated group offered 5.5 times $517,549, an enterprise value of $2,846,520, which left the owner $1,213,799 of cash at closing.
Worked in full in The Audiology Practice Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback
Free: the Hearing Care Practice Revenue per Patient and Break-Even Calculator, an Excel workbook that returns revenue per fitted patient and per appointment, the hearing aid gross margin, the devices kept a month to break even and what five more points of conversion are worth.
An audiology practice is worth its earnings times a multiple, and the first question is which earnings. Seller's discretionary earnings (SDE) are EBITDA plus the owner's salary and its burden: earnings before any pay to the owner. An audiologist who will buy the practice and see its patients herself reads SDE. Adjusted EBITDA is SDE less the market cost of an employed audiologist to do the owner's clinical days. A group that must pay someone to see those patients reads that.
In the book's fictional case, Pellastone Hearing Care, that market cost is set at $136,823 a year (a salary of $122,000 plus burden), close to what the practice already paid its associate for the same number of clinic days. SDE was $340,547 in FY2025 and $637,150 in FY2026; adjusted EBITDA $203,724 and $500,327. No market multiple is quoted here, because none was verified from a primary source; the multiple below is the buyer's figure in a fictional letter of intent.
The trap: an SDE figure multiplied by an EBITDA multiple. The owner's pay is then both added back and still owed to whoever does her work. In the case, applying the letter's 5.5 times to SDE of $637,150 would give $3,504,325, $657,805 more than the letter: $752,527 for earnings that go to the owner's salary after the sale, less $94,722 for a one-time add-back the letter counts and SDE does not.
On 14 October 2026 a hearing care group affiliated with a hearing aid manufacturer (a consolidator, not named) sent the owner a letter of intent. Its arithmetic:
| Line | Amount |
|---|---|
| FY2026 EBITDA | $489,106 |
| Add back: the owner's salary and burden | $148,044 |
| SDE | $637,150 |
| Less: market cost of an audiologist for the owner's clinical days | −$136,823 |
| Add back: second site pre-opening costs, treated as one-time | $17,222 |
| Adjusted EBITDA | $517,549 |
Enterprise value = $517,549 × 5.5 = $2,846,520, which is 4.47 times SDE (a ratio the buyer does not use)
The structure depends on the state. In the letter, the group's operating company would buy the assets and employ the audiologists, as counsel structures it; whether a company not owned by a licensed person may own the practice, employ audiologists and sell hearing aids varies by state. The group would also move most purchases to its affiliated manufacturer after closing.
The book goes further: seven Excel workbooks (revenue per patient, conversion and hearing aid margin, associate pay, equipment lease or loan, break-even, purchase and SBA loan, offer to cash), each with an exercise and its answer. See The Audiology Practice Owner · PDF, $19.99
A buyer reads more than one line of earnings. In the case the owner's clinic days produced $903,035 of the $2,064,790 of production in FY2026, 43.7%: the more of the practice sits in her chair, the more the buyer must pay to replace her and the more it will want her to stay. Hearing aids after returns were 87.9% of revenue and insurers and administrators paid 16.4%, the mix a buyer tests for quality of revenue. Conversion at the first site was 42.0%. The second site contributed $21,937 in its fourth quarter, the evidence a buyer reads for growth. Patients fitted in the two years may come back for new devices in four to six years on the case's assumption, which the case does not count as revenue. A manufacturer's purchase commitment, and a loan due on a sale, come with the price too.
Enterprise value is not what the owner receives. The letter is cash-free and debt-free: every loan is repaid from the price, fees come off, and part of the equity is rolled into the buyer.
| Line | Amount |
|---|---|
| Enterprise value | $2,846,520 |
| SBA loan for the purchase repaid | −$800,690 |
| SBA loan for the second site repaid | −$156,194 |
| Manufacturer's loan, due on the sale, repaid | −$68,012 |
| Equipment lease balance repaid | −$110,392 |
| Seller note with accrued interest repaid | −$55,988 |
| Equity value | $1,655,244 |
| Transaction fees (3% of enterprise value + $25,000 legal) | −$110,396 |
| Rollover, 20% of equity value, into the group's holding company | −$331,049 |
| Cash to the owner at closing | $1,213,799 |
Outside the price, the PLLC keeps its own cash ($228,694) and collects its receivables ($34,959). The rollover is equity in the buyer's holding company, not cash, and is worth what that company is worth when it is sold; the article on how rollover equity is calculated covers the mechanics. Once the bank's loans are repaid, the owner's personal guarantees end with them.
After the sale the owner would work for the group's operating company, 16 clinic days a month, at $122,000 a year ($136,823 with burden): exactly the market cost already deducted from SDE. Her future pay is a cost of the buyer, counted once, neither part of the price nor taken twice. Any non-compete in the purchase or employment agreement is a matter of state law.
Half a turn of multiple moves the owner's cash far more than the price, because the debt does not shrink with it:
| Line | 5.5 times | 5.0 times |
|---|---|---|
| Enterprise value | $2,846,520 | $2,587,745 |
| Debt repaid | $1,191,276 | $1,191,276 |
| Fees | $110,396 | $102,632 |
| Rollover | $331,049 | $279,294 |
| Cash at closing | $1,213,799 | $1,014,543 |
The price fell by 9.1% and the cash at closing by 16.4%.
An individual buyer financing with a 7(a) loan would face the SBA's SOP 50 10 8.1, effective 1 October 2026: an equity injection of at least 10% of total project cost, seller debt counted only on full standby, and limited sources providing no more than half of it. On the letter's price alone, 10% is $284,652 and half of that $142,326, before working capital and closing costs. That buyer would also price SDE, not adjusted EBITDA, and the lender's coverage test would decide how much of it the loan could carry.
Rules checked on 18 November 2026, federal only, and not legal, tax, accounting or clinical advice. Pellastone Hearing Care, its bank, lessor, landlord, manufacturer and buyer are fictional: every case figure is a teaching assumption, not a market norm. State law is for counsel in the practice's state.
No market multiple is given here, because none was verified from a primary source; buyers set it from size, growth, the owner's share of production, the revenue mix and risk. In the book's fictional letter of intent a manufacturer-affiliated group offered 5.5 times adjusted EBITDA.
An audiologist who will work in the practice reads SDE, which adds back the owner's pay. A group reads adjusted EBITDA, SDE less the market cost of an audiologist. In the case SDE was $637,150 and the buyer's adjusted EBITDA $517,549.
Because the loans are repaid from the price, fees are paid and part of the equity is rolled into the buyer. In the case an enterprise value of $2,846,520 left $1,213,799 of cash at closing, plus a rollover of $331,049.
Read the agreement. In the case the manufacturer's loan was due in full on a sale of substantially all the assets, so its $68,012 balance was repaid from the price and the purchase commitment ended with it; what a real agreement provides is for counsel.
This article is one chapter's worth of arithmetic from The Audiology Practice Owner, which follows one fictional two-site hearing care practice for 24 months: the purchase with an SBA 7(a) loan, diagnostics and Medicare's hearing aid exclusion, bundled and unbundled prices, conversion, returns and device margin, over-the-counter hearing aids, associate pay, a manufacturer's loan, break-even, a second location and a manufacturer-affiliated group's letter of intent.
DRM-free PDF, $19.99 · Paperback, $32.99, shipped worldwide · Free calculator